Can an extra inhaler boost lung clearance in cystic fibrosis patients already on breakthrough drugs?

NCT ID NCT05740618

First seen Nov 01, 2025 · Last updated Jun 08, 2026 · Updated 29 times

Summary

This study looked at whether adding an inhaled medication called Bronchitol (mannitol) can further improve mucus clearance in people with cystic fibrosis who have moderate to severe lung disease and are already taking a triple-combination drug (elexacaftor/tezacaftor/ivacaftor). Fourteen adults participated, and researchers measured how quickly radioactive particles cleared from the lungs over one hour. The goal was to see if combining these treatments provides extra benefit beyond the modulator alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

Conditions

Explore the condition pages connected to this study.